Search
for
Sort by
Research 121–150 of 375
- Incidence of androgenic dermatologic side effects following placement of a levonorgestrel intrauterine device for menorrhagia: A survey-based study
- Evaluation and Treatment of Hirsutism in Premenopausal Women: An Endocrine Society Clinical Practice Guideline
- Drug interactions between common dermatological medications and the oral anti-COVID-19 agents nirmatrelvir-ritonavir and molnupiravir
- Neurosteroidogenesis Today: Novel Targets for Neuroactive Steroid Synthesis and Action and Their Relevance for Translational Research
- Simultaneous Determination of Selected Steroids with Neuroactive Effects in Human Serum by Ultrahigh-Performance Liquid Chromatography–Tandem Mass Spectrometry
- Current evaluation of amenorrhea
- Management of Hair Loss
- Combined Oral Contraception and Bicalutamide in Polycystic Ovary Syndrome and Severe Hirsutism: A Double-Blind Randomized Controlled Trial
- Integrated Model of Care for Polycystic Ovary Syndrome
- Steroid Hormones
- Review on Diagnostic and Managerial Consequences of PCOS Among Females
- Pharmacological Options for Treatment of Hyperandrogenic Disorders
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Endocrine treatment of benign prostatichypertrophy: Current concepts
- Cancer risk in polycystic ovary syndrome patients: Common treatments and future perspectives
- Polycystic Ovary Syndrome
- The Evaluation and Management of Hirsutism
- Steroid Sulfatase: Molecular Biology, Regulation, and Inhibition
- Hypertension and Cicatricial Hair Loss: Defining High Value Symptom Clusters within Reproductive Aging
- Progesterone Promotes Anti-Anxiety/Depressant-like Behavior and Trophic Actions of BDNF in the Hippocampus of Female Nuclear Progesterone Receptor, but Not 5α-Reductase, Knockout Mice
- Progress in Topical and Transdermal Drug Delivery Research—Focus on Nanoformulations
- Current aspects of polycystic ovary syndrome II: treatment of hyperandrogenism, insulin resistance and infertility
- Miscellaneous Exogenous Hormones and Breast Diseases: A Matter of Concern for the Gynecologist
- Hormonal Treatment for Skin Androgen-Related Disorders
- Improved Transgender Care in the ED
- Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome
- Toxic epidermal necrolysis caused by etonogestrel implantation: A rare presentation
- Association of Acne Tarda with Endocrinological Disorders
- Progesterone Inhibits the Growth of Human Neuroblastoma: In Vitro and In Vivo Evidence